BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/12/2025 8:18:29 AM | Browse: 34 | Download: 138
 |
Received |
|
2025-03-13 12:51 |
|
Peer-Review Started |
|
2025-03-19 00:16 |
|
First Decision by Editorial Office Director |
|
2025-04-27 04:36 |
|
Return for Revision |
|
2025-04-27 05:09 |
|
Revised |
|
2025-05-10 16:34 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-07-10 02:46 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-07-10 09:19 |
|
Articles in Press |
|
2025-07-10 09:19 |
|
Edit the Manuscript by Language Editor |
|
2025-07-15 22:38 |
|
Typeset the Manuscript |
|
2025-08-01 02:33 |
|
Publish the Manuscript Online |
|
2025-08-12 08:18 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Glucagon-like peptide and its receptor agonists for the treatment of rheumatic diseases
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Elie Chamchoum, Nadia Katrib, Nicolas Nassif, Yara Ratel and Mohamad Ali Rida |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohamad Ali Rida, Assistant Professor, MD, Department of Internal Medicine, Clemenceau Medical Center, Clemenceau, Beirut 1, Lebanon. mohamad.ali.rida@gmail.com |
| Key Words |
Glucagon-like peptide-1 agonists; Osteoarthritis; Rheumatoid arthritis; Psoriatic arthritis; System lupus erythematosus; Inflammation |
| Core Tip |
Growing evidence suggests that glucagon-like peptide-1 and its receptor agonists could be an effective treatment option not only for metabolic disorders but also for a range of autoimmune and inflammatory diseases. They may protect cartilage and reduce joint inflammation, lower the levels of inflammatory cytokines, helping prevent further joint damage and address both the metabolic and inflammatory aspects, reducing cytokine levels and potentially improving disease outcomes. |
| Publish Date |
2025-08-12 08:18 |
| Citation |
Chamchoum E, Katrib N, Nassif N, Ratel Y, Rida MA. Glucagon-like peptide and its receptor agonists for the treatment of rheumatic diseases. World J Exp Med 2025; 15(3): 107020 |
| URL |
https://www.wjgnet.com/2220-315X/full/v15/i3/107020.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v15.i3.107020 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
